Adverse effects of drug therapies on male and female sexual function
Th. Stadler(Ludwig-Maximilians-Universität München), Christian G. Stief(LMU Klinikum), A. Becker(Ludwig-Maximilians-Universität München), Markus Bader(Muljibhai Patel Urological Hospital), Stefan Ückert(Medizinische Hochschule Hannover), Michael Staehler(München Klinik)
Cited by 27
Related Papers
Single-Step Percutaneous Nephrolithotomy (Microperc): The Initial Clinical Report
|The Journal of Urology|2011|276
Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort
|European Urology|2014|206
The “All-Seeing Needle”: Initial Results of an Optical Puncture System Confirming Access in Percutaneous Nephrolithotomy
|European Urology|2011|181
Photodynamic Therapy of Bladder Cancer – A Phase I Study Using Hexaminolevulinate (HAL)
|Urologic Oncology Seminars and Original Investigations|2012|92
Chromosome 9 deletions are more frequent than <i>FGFR3</i> mutations in flat urothelial hyperplasias of the bladder
|International Journal of Cancer|2006|90